Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

Author
S. Shapiro
H. Yin
O. H. Y. Yu
S. Rej
S. Suissa
L. Azoulay
Keywords
Humans
*Diabetes Mellitus, Type 2/drug therapy/psychology/epidemiology
Male
Female
*Glucagon-Like Peptide-1 Receptor
Middle Aged
*Dipeptidyl-Peptidase IV Inhibitors/therapeutic use/adverse effects
Aged
*Hypoglycemic Agents/therapeutic use/adverse effects
*Suicidal Ideation
Cohort Studies
Sodium-Glucose Transporter 2 Inhibitors/therapeutic use/adverse effects
United Kingdom/epidemiology
Suicide/statistics & numerical data/psychology
Self-Injurious Behavior/epidemiology
Adult
Risk Factors
Glucagon-like peptide-1 receptor agonists
Year of Publication
2025
Journal
Bmj
Volume
388
Number of Pages
e080679
ISBN Number
0959-8138 (Print)
0959-8138
Accession Number
40010803
DOI
10.1136/bmj-2024-080679